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Editorial
Frances A. Pitlick, Ph.D.
Commemorating 12 Years of Distinguished Service
In August 1988, Frances A. Pitlick was appointed as
Executive Officer of the American Association of Pathol-
ogists (AAP) and oversaw its transition to the American
Society for Investigative Pathology (ASIP) in the early
1990s. Her resignation as Executive Officer of ASIP, ef-
fective March 1, 2001, marks the end of an important
chapter in the organization’s history.
Dr. Pitlick’s years of leadership were rich in events with
significant impact on the field of Pathology, affecting
individual scientists, departments, and public policy.
Overall, these years of accomplishment have secured a
prominent place for Pathology in the biomedical commu-
nity. Several Past Presidents of ASIP recently reflected on
these achievements and the relationships they enjoyed
with Dr. Pitlick during their tenures. Their sometimes poi-
gnant, always informative comments are presented here.
“Dr. Pitlick’s distinguished service to the Society re-
sulted in an extremely broad range of accomplishments.
Among others, ASIP began self-publishing The American
Journal of Pathology, giving the Society full governance of
the Journal’s operations. This gave ASIP the ability to
make important and immediate decisions such as in-
creasing the number of pages published and harnessing
technological advances including online publication.”
Dorothy F. Bainton, President, 1990
“With the authority of self-publishing came the power to
create The Journal of Molecular Diagnostics, which in less
than a year-and-a-half achieved indexing status in Index
Medicus/MEDLINE and acceptance for ranking by the
Institute for Scientific Information. That journal, co-pub-
lished with the Association for Molecular Pathology, is an
example of the work that Dr. Pitlick is so highly regarded
for: bringing together resources, people, and organiza-
tions to accomplish mutually beneficial goals.”
Vinay Kumar, President, 1998
“Fran Pitlick guided the AAP to its true identity and
reorganization as the ASIP. This transition was the result
of examination of evolution of the field and of the Society.
Recognition of the Society’s members as primarily aca-
demic investigators and of the need to focus the Society’s
agenda on the investigative aspects of Pathology,
namely pathogenesis and modern molecular cell biology
of pathological processes, was progressively realized
and agreed to by the Council.”
“Fran was Executive Officer of ASIP during the reorga-
nization of the Federation of American Societies for Ex-
perimental Biology (FASEB), a period of considerable
turmoil. The success of bringing FASEB forward as a
federation of independent societies and the refocusing of
FASEB on the issues it could best address, such as
public affairs and political action, were aided by the
steady contributions of Fran Pitlick.”
Thomas S. Edgington, President, 1989
“We sought to define the intellectual scope of ‘investi-
gative’ pathology in a way that would attract the partici-
pation of basic scientists as well as clinician-scientists in
multiple disciplines, at all levels of inquiry from the mol-
ecule to the whole organism. In addition to defining our
own organization’s ‘identity’, we also were embroiled in
the bigger issue of the restructuring of FASEB. These
were challenging times for all concerned; throughout
them, Dr. Pitlick provided outstanding service as ASIP’s
senior resident representative in Bethesda, actively col-
laborating with her colleagues in the other FASEB soci-
eties to bring action out of chaos, always with a resource-
ful and positive attitude that was reassuring to those
around her.
“Beyond these internal challenges, she had a sound
appreciation of the opportunities that geographic prox-
imity could afford in the realm of national politics. She
charted the shortest path between the ASIP/FASEB of-
fices in Bethesda and the corridors of Capitol Hill, and
encouraged many of our membership to make that pil-
grimage in the name of biomedical research funding.”
Michael A. Gimbrone, Jr., President, 1992
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“There was reason for concern that National Institutes
of Health (NIH) study sections, which were focused on
mechanisms and experimental models of disease, could
regularly be dominated by reviewers who were neither
pathologists nor members of Pathology departments. Dr.
Pitlick quickly identified the appropriate NIH contacts and
obtained the relevant data for selected study sections.
From the data that she assembled, it was easy to sub-
stantiate that experimental pathologists were not always
represented on study sections that are key to our disci-
pline. In pursuing this project, Dr. Pitlick demonstrated
the qualities that made her so effective. Above all, she
has excellent judgment. She knew or quickly found the
people who could solve the problem at hand. She was
willing and able to work with the right balance of inde-
pendence so that she spared the president and council
from work she could handle by herself, yet kept them
informed as the work proceeded.”
Michael E. Lamm, President, 1991
“The National Center for Human Genome Research at
NIH, directed by Dr. Francis Collins, had an active com-
mittee charged with recommending policy for genetic
research that involved the use of human tissues. This
group was designated as The Ethical, Legal and Social
Issues Working Group (ELSI). The ELSI Working Group
consisted of members from the fields of law, social work,
ethics, pediatrics, and genetic disease advocacy
groups, but no representatives from Pathology, the cus-
todians of human tissue archives. In a very short period of
time, it became clear that a great deal of momentum had
developed to adopt policies that had tremendous impli-
cations for Pathology, yet pathologists had not been in-
volved in any of the discussions or actions. Articles be-
gan to appear in press expressing the opinions of some
members of ELSI that, if adopted, would create barriers
to important research and would inadvertently undermine
the quality of patient care. Language began to appear in
the Congressional Record along a similar vein, and stat-
utes began to be proposed by some state legislatures
that would impose restrictions on the use of human tis-
sues. All of this had tremendous implications for Pathol-
ogy and for pathologists. Fran Pitlick was among the first
to recognize the perilous situation and was responsible
for initiating, organizing, and coordinating the response
of the Pathology community. Fran was the catalyst who
brought together the many professional societies that
represented the spectrum of pathologists: the research-
ers, the clinical practitioners, the educators, and the com-
munity hospital pathologists. She was on the phone get-
ting people and Pathology societies involved. Wherever
there was activity connected with regulation of genetic
research, Fran seemed to always know about it and to
see that Pathology was represented and the views of
pathologists were heard.”
Richard G. Lynch, President, 1995
“Through her exceptional understanding of the issues
and the people involved, Dr. Pitlick cultivated a hub of
Pathology activities at 9650 Rockville Pike. She was in-
strumental in attracting a number of organizations to the
ASIP headquarters, including the Association for Molec-
ular Pathology, the Intersociety Committee of Pathology
Information, the Association of Pathology Informatics,
and the International Society for Biological and Environ-
mental Repositories. In addition, she directed the Asso-
ciation for Pathology Chairs and Universities Affiliated for
Research in Experimental Pathology, thus creating a
uniquely cooperative and collaborative atmosphere
among these Pathology-related groups. In all of her en-
deavors, she has acted selflessly and has exemplified
the highest standards of integrity.”
Mark E. Sobel, President, 1999
Each of the Past Presidents, alternately described Dr.
Pitlick as never complaining, always willing to help, gen-
tle and effective, exceptionally attentive to detail, wise,
dependable, steady, unflappable, and, above all, exhib-
iting tremendous dedication to research and education in
Pathology.
The American Society for Investigative Pathology, her
staff, colleagues, and fellow scientists are grateful for her
many contributions and trust that her substantial legacy
will be maintained and strengthened by her successors.
Priscilla Smith Markwood
Publications Manager, ASIP
Bethesda, Maryland
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